Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,042,600 | 872,500 | 769,000 | 1,247,800 | 1,198,100 |
| Marketable Securities | 466,700 | 381,700 | 446,300 | 490,900 | 317,700 |
| Receivables | 816,900 | 779,300 | 699,100 | 661,400 | 679,200 |
| Inventories | 980,200 | 914,300 | 875,500 | 757,800 | 740,000 |
| Other current assets | 217,400 | 190,300 | 195,900 | 267,600 | 248,800 |
| TOTAL | $3,647,000 | $3,257,200 | $3,095,800 | $3,513,900 | $3,263,100 |
| Non-Current Assets | |||||
| PPE Net | 1,662,200 | 1,646,000 | 1,632,800 | 1,566,400 | 1,559,900 |
| Investments And Advances | 856,200 | 1,066,700 | 1,239,000 | 1,381,000 | 1,490,800 |
| Intangibles | 1,730,900 | 1,755,200 | 1,449,500 | 1,425,200 | 1,484,800 |
| Other Non-Current Assets | 1,107,700 | 926,100 | 875,400 | 751,700 | 626,500 |
| TOTAL | $5,357,000 | $5,394,000 | $5,196,700 | $5,124,300 | $5,162,000 |
| Total Assets | $9,004,000 | $8,651,200 | $8,292,500 | $8,638,200 | $8,425,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 193,000 | 180,800 | 201,900 | 154,900 | 162,500 |
| Accrued Expenses | 939,900 | 876,100 | 795,000 | 739,500 | 783,300 |
| TOTAL | $1,157,200 | $1,082,000 | $1,022,400 | $917,900 | $969,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 596,700 | 596,500 | 596,300 | 596,200 | 596,000 |
| aiOther Non-Current Liabilities | 805,200 | 910,700 | 867,100 | 906,300 | 916,400 |
| TOTAL | $1,400,300 | $1,507,200 | $1,463,400 | $1,502,500 | $1,512,400 |
| Total Liabilities | $2,557,500 | $2,589,200 | $2,485,800 | $2,420,400 | $2,481,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 607,916 | 606,218 | 608,313 | 618,261 | 619,943 |
| Common Shares | 649,100 | 647,100 | 646,300 | 645,700 | 645,000 |
| Retained earnings | 8,237,600 | 7,930,500 | 7,590,000 | 7,191,600 | 6,848,100 |
| Other shareholders' equity | -184,700 | -170,900 | -254,900 | -256,000 | -224,000 |
| TOTAL | $6,446,500 | $6,062,000 | $5,806,700 | $6,217,800 | $5,943,600 |
| Total Liabilities And Equity | $9,004,000 | $8,651,200 | $8,292,500 | $8,638,200 | $8,425,100 |